20 days and counting..............................
Post# of 72430
![](/assets/46931549/no_avatar_available_thumb.jpg)
4/9/2019 PR
The Company is now positioning itself to further advance Brilacidin, most immediately, in its planned Phase 3 Oral Mucositis program, and in mid-stage testing for Inflammatory Bowel Disease.
Leo's email to me was on the nose. It's a waiting game and not with BP..Per Leo
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)